These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 16788944)

  • 1. Lack of activated Smad2 in transforming growth factor-beta signaling is an unfavorable prognostic factor in patients with esophageal squamous cell carcinoma.
    Fukuchi M; Nakajima M; Miyazaki T; Masuda N; Osawa H; Manda R; Tsukada K; Kato H; Kuwano H
    J Surg Oncol; 2006 Jul; 94(1):51-6. PubMed ID: 16788944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of the expression of Smad6 and Smad7, as inhibitory Smads of the TGF-beta superfamily, in esophageal squamous cell carcinoma.
    Osawa H; Nakajima M; Kato H; Fukuchi M; Kuwano H
    Anticancer Res; 2004; 24(6):3703-9. PubMed ID: 15736400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased Smad4 expression in the transforming growth factor-beta signaling pathway during progression of esophageal squamous cell carcinoma.
    Fukuchi M; Masuda N; Miyazaki T; Nakajima M; Osawa H; Kato H; Kuwano H
    Cancer; 2002 Aug; 95(4):737-43. PubMed ID: 12209716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Defective transforming growth factor beta signaling pathway in head and neck squamous cell carcinoma as evidenced by the lack of expression of activated Smad2.
    Muro-Cacho CA; Rosario-Ortiz K; Livingston S; Muñoz-Antonia T
    Clin Cancer Res; 2001 Jun; 7(6):1618-26. PubMed ID: 11410498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Smad4 and transforming growth factor beta1 expression in patients with squamous cell carcinoma of the esophagus.
    Natsugoe S; Xiangming C; Matsumoto M; Okumura H; Nakashima S; Sakita H; Ishigami S; Baba M; Takao S; Aikou T
    Clin Cancer Res; 2002 Jun; 8(6):1838-42. PubMed ID: 12060625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of RCAS1 in esophageal squamous cell carcinoma is associated with a poor prognosis.
    Kato H; Nakajima M; Masuda N; Faried A; Sohda M; Fukai Y; Miyazaki T; Fukuchi M; Tsukada K; Kuwano H
    J Surg Oncol; 2005 May; 90(2):89-94. PubMed ID: 15844180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Smad2 and Smad3 phosphorylated at both linker and COOH-terminal regions transmit malignant TGF-beta signal in later stages of human colorectal cancer.
    Matsuzaki K; Kitano C; Murata M; Sekimoto G; Yoshida K; Uemura Y; Seki T; Taketani S; Fujisawa J; Okazaki K
    Cancer Res; 2009 Jul; 69(13):5321-30. PubMed ID: 19531654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of Smad signaling enhances collagenase-3 (MMP-13) expression and invasion of head and neck squamous carcinoma cells.
    Leivonen SK; Ala-Aho R; Koli K; Grénman R; Peltonen J; Kähäri VM
    Oncogene; 2006 Apr; 25(18):2588-600. PubMed ID: 16407850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of epidermal growth factor receptor in esophageal and esophagogastric junction adenocarcinomas: association with poor outcome.
    Wang KL; Wu TT; Choi IS; Wang H; Resetkova E; Correa AM; Hofstetter WL; Swisher SG; Ajani JA; Rashid A; Albarracin CT
    Cancer; 2007 Feb; 109(4):658-67. PubMed ID: 17211865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TGF-beta receptor 2 downregulation in tumour-associated stroma worsens prognosis and high-grade tumours show more tumour-associated macrophages and lower TGF-beta1 expression in colon carcinoma: a retrospective study.
    Bacman D; Merkel S; Croner R; Papadopoulos T; Brueckl W; Dimmler A
    BMC Cancer; 2007 Aug; 7():156. PubMed ID: 17692120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced axin protein expression is associated with a poor prognosis in patients with squamous cell carcinoma of esophagus.
    Li AF; Hsu PK; Tzao C; Wang YC; Hung IC; Huang MH; Hsu HS
    Ann Surg Oncol; 2009 Sep; 16(9):2486-93. PubMed ID: 19582507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in Smad4 expression in human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck squamous cell carcinoma.
    Báez A; Cantor A; Fonseca S; Marcos-Martinez M; Mathews LA; Muro-Cacho CA; Muñoz-Antonia T
    Clin Cancer Res; 2005 May; 11(9):3191-7. PubMed ID: 15867212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced membranous beta-catenin protein expression is associated with metastasis and poor prognosis in squamous cell carcinoma of the esophagus.
    Hsu PK; Li AF; Wang YC; Hsieh CC; Huang MH; Hsu WH; Hsu HS
    J Thorac Cardiovasc Surg; 2008 May; 135(5):1029-35. PubMed ID: 18455580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of caveolin-1 in esophageal squamous cell carcinoma correlates with lymph node metastasis and pathologic stage.
    Kato K; Hida Y; Miyamoto M; Hashida H; Shinohara T; Itoh T; Okushiba S; Kondo S; Katoh H
    Cancer; 2002 Feb; 94(4):929-33. PubMed ID: 11920460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased expression of c-Ski as a co-repressor in transforming growth factor-beta signaling correlates with progression of esophageal squamous cell carcinoma.
    Fukuchi M; Nakajima M; Fukai Y; Miyazaki T; Masuda N; Sohda M; Manda R; Tsukada K; Kato H; Kuwano H
    Int J Cancer; 2004 Mar; 108(6):818-24. PubMed ID: 14712482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significance of macrophage chemoattractant protein-1 expression and macrophage infiltration in squamous cell carcinoma of the esophagus.
    Koide N; Nishio A; Sato T; Sugiyama A; Miyagawa S
    Am J Gastroenterol; 2004 Sep; 99(9):1667-74. PubMed ID: 15330899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A tale of two proteins: differential roles and regulation of Smad2 and Smad3 in TGF-beta signaling.
    Brown KA; Pietenpol JA; Moses HL
    J Cell Biochem; 2007 May; 101(1):9-33. PubMed ID: 17340614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Matrix metalloproteinases expression correlates with survival in patients with esophageal squamous cell carcinoma.
    Gu ZD; Li JY; Li M; Gu J; Shi XT; Ke Y; Chen KN
    Am J Gastroenterol; 2005 Aug; 100(8):1835-43. PubMed ID: 16086722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-level expression of the Smad ubiquitin ligase Smurf2 correlates with poor prognosis in patients with esophageal squamous cell carcinoma.
    Fukuchi M; Fukai Y; Masuda N; Miyazaki T; Nakajima M; Sohda M; Manda R; Tsukada K; Kato H; Kuwano H
    Cancer Res; 2002 Dec; 62(24):7162-5. PubMed ID: 12499250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD24 expression is a novel prognostic factor in esophageal squamous cell carcinoma.
    Sano A; Kato H; Sakurai S; Sakai M; Tanaka N; Inose T; Saito K; Sohda M; Nakajima M; Nakajima T; Kuwano H
    Ann Surg Oncol; 2009 Feb; 16(2):506-14. PubMed ID: 19050962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.